ANDA 218933, held by Avion Pharms. Desogestrel; Ethinyl Estradiol.
As of Nov 15, 2026, ANDA 218933 (Averi), held by Avion Pharms, was first approved by FDA on May 2, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 2, 2025 | Original application | Approved | None posted |
| Averi0.15MG;0.03MG · tablet;oral-21 | Desogestrel; Ethinyl Estradiol | Rx |
| Averi0.15MG;0.03MG · tablet;oral-28 | Desogestrel; Ethinyl Estradiol | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
